Machine learning for modeling the progression of Alzheimer disease dementia using clinical data: a systematic literature review
Open accessThe DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
Objective: Alzheimer disease (AD) is the most common cause of dementia, a syndrome characterized by cognitive impairment severe enough to interfere with activities of daily life. We aimed to conduct a systematic literature review (SLR) of studies that applied machine learning (ML) methods to clinical data derived from electronic health records in order to model risk for progression of AD dementia. Materials and Methods: We searched for articles published between January 1, 2010, and May 31, 2020, in PubMed, Scopus, ScienceDirect, IEEE Explore Digital Library, Association for Computing Machinery Digital Library, and arXiv. We used predefined criteria to select relevant articles and summarized them according to key components of ML analysis such as data characteristics, computational algorithms, and research focus. Results: There has been a considerable rise over the past 5 years in the number of research papers using ML-based analysis for AD dementia modeling. We reviewed 64 relevant articles in our SLR. The results suggest that majority of existing research has focused on predicting progression of AD dementia using publicly available datasets containing both neuroimaging and clinical data (neurobehavioral status exam scores, patient demographics, neuroimaging data, and laboratory test values). Discussion: Identifying individuals at risk for progression of AD dementia could potentially help to personalize disease management to plan future care. Clinical data consisting of both structured data tables and clinical notes can be effectively used in ML-based approaches to model risk for AD dementia progression. Data sharing and reproducibility of results can enhance the impact, adaptation, and generalizability of this research.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The FAIR Guiding Principles for scientific data management and stewardship
Wilkinson, M. D., Dumontier, M., Aalbersberg, I. J., Appleton, G., Axton, M., Baak, A., Blomberg, N., Boiten, J.-W., da Silva Santos, L. B., Bourne, P. E., et al. (2016) · Scientific Data · doi:10.1038/sdata.2016.18 · Cited by 18,423
The global prevalence of dementia: a systematic review and metaanalysis.
Prince, M., Bryce, R., Albanese, E., Wimo, A., Ribeiro, W., & Ferri, C. P. (2013) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2012.11.007 · Cited by 4,941 · cited 2×
“AD dementia affects millions of people worldwide and is currently the sixth leading cause of death in the United States.(3,4) AD-related brain pathology, which includes the accumulation and deposition of amyloid-b peptide and tau protein, begins almost 10–20 years before the onset of dementia symptoms.”
BackgroundBallard, C., Gauthier, S., Corbett, A., Brayne, C., Aarsland, D., & Jones, E. (2011) · The Lancet · doi:10.1016/s0140-6736(10)61349-9 · Cited by 2,336
Preclinical Alzheimer’s Disease: Definition, Natural History, and Diagnostic Criteria
Dubois, B., Hampel, H., Feldman, H. H., Scheltens, P., Aisen, P., Andrieu, S., Bakardjian, H., Benali, H., Bertram, L., Blennow, K., et al. (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.02.002 · Cited by 1,925
George, H., Duke Jon, D., Shah Nigam, H., Reich Christian, G., Vojtech, H., Schuemie Martijn, J., Suchard Marc, A., Woong, P. R., Kei, W. I. C., Rijnbeek Peter, R., et al. (2015) · Studies in Health Technology and Informatics · doi:10.3233/978-1-61499-564-7-574 · Cited by 1,542 · cited 1×
“OHDSI produces tools like the OMOP (Observational Medical Outcomes Partnership) Common Data Model, which transforms data within disparate observational databases into a common representation (terminologies, vocabularies, and coding schemes) so that they can be analyzed using standardized analytics tools.(96) Despite t…”
MethodKnopman, D. S., DeKosky, S. T., Cummings, J. L., Chui, H., Corey–Bloom, J., Relkin, N., Small, G. W., Miller, B., & Stevens, J. C. (2001) · Neurology · doi:10.1212/wnl.56.9.1143 · Cited by 1,410
Predicting alzheimer’s disease progression using multi-modal deep learning approach
Lee, G., Nho, K., Kang, B., Sohn, K.-A., Kim, D., Initiative, F. A. D. N., Weiner, M. W., Aisen, P., Petersen, R., Jack, C. R., et al. (2019) · Scientific Reports · doi:10.1038/s41598-018-37769-z · Cited by 406
Questions for artificial intelligence in health care
Maddox, T. M., Rumsfeld, J. S., & Payne, P. R. O. (2019) · JAMA · doi:10.1001/jama.2018.18932 · Cited by 385 · cited 1×
“18 Machine learning (ML), a branch of AI, can model the relationship between the input quantities and clinical outcomes, discover hidden patterns within large-scale data, and make inferences or decisions that help in more accurate clinical decision-making.”
BackgroundSelf-citationHow to develop machine learning models for healthcare
Chen, P.-H. C., Liu, Y., & Peng, L. (2019) · Nature Materials · doi:10.1038/s41563-019-0345-0 · Cited by 274 · cited 1×
“20 In our review, we include studies using ML for the purpose of predictive modeling (such as decision trees, support vector machines [SVM], k-means clustering) and exclude studies us-ing statistical methods for cohort summarization and hypothesis testing (such as odds ratio, Chi-square…”
MethodShaw, L. M., Arias, J., Blennow, K., Galasko, D., Molinuevo, J. L., Salloway, S., Schindler, S., Carrillo, M. C., Hendrix, J. A., Ross, A., et al. (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.07.220 · Cited by 266
Self-citationMachine learning for comprehensive forecasting of Alzheimer’s Disease progression
Fisher, C. K., Smith, A. M., Walsh, J. R., Diseases, C. A. M., Simon, A. J., Edgar, C., Jack, C. R., Holtzman, D., Russell, D., Hill, D., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-49656-2 · Cited by 223
Secondary Use of Electronic Health Record: Opportunities and Challenges
Shah, S. M., & Khan, R. A. (2020) · IEEE Access · doi:10.1109/access.2020.3011099 · Cited by 158
Bhagwat, N., Viviano, J. D., Voineskos, A. N., Chakravarty, M. M., & Initiative, A. D. N. (2018) · PLOS Computational Biology · doi:10.1371/journal.pcbi.1006376 · Cited by 157
Albright, J., & Initiative, A. D. N. (2019) · Alzheimer's & Dementia: Translational Research & Clinical Interventions · doi:10.1016/j.trci.2019.07.001 · Cited by 104
Martí-Juan, G., Sanroma-Guell, G., & Piella, G. (2020) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2020.105348 · Cited by 85 · cited 2×
“Machine learning (ML), a branch of AI, can model the relationship between the input quantities and clinical outcomes, discover hidden patterns within largescale data, and make inferences or decisions that help in more accurate clinical decision-making.(19) However, computational hypotheses generated by ML models still…”
BackgroundMethod
Research works printed but not linked: 64
- McKhann, 2011, The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease, Alzheimers Dement, 7, 263, 10.1016/j.jalz.2011.03.005 · DOI · Paper page
- Ferri, 2005, Global prevalence of dementia: a Delphi consensus study, Lancet, 366, 2112, 10.1016/S0140-6736(05)67889-0 · DOI · Paper page
- Villemagne, 2013, Amyloid beta deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study, Lancet Neurol, 12, 357, 10.1016/S1474-4422(13)70044-9 · DOI · Paper page
- Musiek, 2013, Alzheimer disease: current concepts & future directions, Mo Med, 110, 395
- Förstl, 1999, Clinical features of Alzheimer’s disease, Eur Arch Psychiatry Clin Neurosci, 249, 288, 10.1007/s004060050101 · DOI · Paper page
- McGinnis, 2011, Clinical Data as the Basic Staple of Health Learning: Creating and Protecting a Public Good: Workshop Summary
- Vaughn, Thoughtless Design of the Electronic Health Record Drives Overuse, but Purposeful Design Can Nudge Improved Patient Care, 10.1136/bmjqs-2017-007578 · DOI
- Bilgel, 2015, International Conference on Information Processing in Medical Imaging
- Chi, 2017, Personalized long-term prediction of cognitive function: using sequential assessments to improve model performance, J Biomed Inform, 76, 78, 10.1016/j.jbi.2017.11.002 · DOI
- Li, 2017, Functional joint model for longitudinal and time-to-event data: an application to Alzheimer's disease, Stat Med, 36, 3560, 10.1002/sim.7381 · DOI
- Johnson, 2013, Appropriate use criteria for amyloid PET: a report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer's Association, Alzheimers Dement, 9, e1, 10.1016/j.jalz.2013.01.002 · DOI · Paper page
- Mills, 2014, Methods and considerations for longitudinal structural brain imaging analysis across development, Dev Cogn Neurosci, 9, 172, 10.1016/j.dcn.2014.04.004 · DOI · Paper page
- Dallora, 2017, Machine learning and microsimulation techniques on the prognosis of dementia: a systematic literature review, PLoS One, 12, e0179804, 10.1371/journal.pone.0179804 · DOI · Paper page
- Pellegrini, 2018, Machine learning of neuroimaging for assisted diagnosis of cognitive impairment and dementia: a systematic review, Alzheimers Dement, 10, 519
- Moher, 2009, Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement, PLoS Med, 6, e1000097, 10.1371/journal.pmed.1000097 · DOI · Paper page
- Wu, 2020, Predicting Alzheimer's disease based on survival data and longitudinally measured performance on cognitive and functional scales, Psychiatry Res, 291, 113201, 10.1016/j.psychres.2020.113201 · DOI
- Lin, 2018, Big data analytical approaches to the NACC dataset: aiding preclinical trial enrichment, Alzheimer Dis Assoc Disord, 32, 18, 10.1097/WAD.0000000000000228 · DOI · Paper page
- Wang, 2018, Predictive modeling of the progression of Alzheimer's disease with recurrent neural networks, Sci Rep, 8, 9161, 10.1038/s41598-018-27337-w · DOI · Paper page
- Ang, 2019, Using data science to diagnose and characterize heterogeneity of Alzheimer's disease, Alzheimers Dement (N Y), 5, 264, 10.1016/j.trci.2019.05.002 · DOI
- Joshi, 2019, Temporal association of neuropsychological test performance using unsupervised learning reveals a distinct signature of Alzheimer's disease status, Alzheimers Dement, 5, 964, 10.1016/j.trci.2019.11.006 · DOI
- Park, 2020, Machine learning prediction of incidence of Alzheimer’s disease using large-scale administrative health data, NPJ Digit Med, 3, 46, 10.1038/s41746-020-0256-0 · DOI · Paper page
- So, 2017, Early diagnosis of dementia from clinical data by machine learning techniques, Appl Sci, 7, 651, 10.3390/app7070651 · DOI
- Cao, 2018, Generalized fused group lasso regularized multi-task feature learning for predicting cognitive outcomes in Alzheimers disease, Comput Methods Programs Biomed, 162, 19, 10.1016/j.cmpb.2018.04.028 · DOI
- Zhang, 2018, A similarity-based approach to leverage multi-cohort medical data on the diagnosis and prognosis of Alzheimer's disease, GigaScience, 7, giy085, 10.1093/gigascience/giy085 · DOI
- Grassi, 2019, A novel ensemble-based machine learning algorithm to predict the conversion from mild cognitive impairment to Alzheimer’s disease using socio-demographic characteristics, clinical information and neuropsychological measures, Front Neurol, 10, 756, 10.3389/fneur.2019.00756 · DOI
- Nori, 2019, Machine learning models to predict onset of dementia: a label learning approach, Alzheimers Dement (N Y), 5, 918, 10.1016/j.trci.2019.10.006 · DOI · Paper page
- Ezzati, 2020, Machine learning predictive models can improve efficacy of clinical trials for Alzheimer’s disease 1, 2, J Alzheimers Dis, 74, 55, 10.3233/JAD-190822 · DOI
- Goyal, 2018, Characterizing heterogeneity in the progression of Alzheimer's disease using longitudinal clinical and neuroimaging biomarkers, Alzheimer Dement, 10, 629, 10.1016/j.dadm.2018.06.007 · DOI · Paper page
- Moore, 2019, Random forest prediction of Alzheimer’s disease using pairwise selection from time series data, PLoS One, 14, e0211558, 10.1371/journal.pone.0211558 · DOI · Paper page
- Spasov, 2019, A parameter-efficient deep learning approach to predict conversion from mild cognitive impairment to Alzheimer's disease, NeuroImage, 189, 276, 10.1016/j.neuroimage.2019.01.031 · DOI · Paper page
- Huang, 2016, Longitudinal clinical score prediction in Alzheimer's disease with soft-split sparse regression based random forest, Neurobiol Aging, 46, 180, 10.1016/j.neurobiolaging.2016.07.005 · DOI · Paper page
- Yao, 2018, An ensemble learning system for a 4-way classification of Alzheimer’s disease and mild cognitive impairment, J Neurosci Methods, 302, 75, 10.1016/j.jneumeth.2018.03.008 · DOI
- Battista, 2017, Optimizing neuropsychological assessments for cognitive, behavioral, and functional impairment classification: a machine learning study, Behav Neurol, 2017, 1850909, 10.1155/2017/1850909 · DOI · Paper page
- Fulton, 2019, Classification of Alzheimer’s disease with and without imagery using gradient boosted machines and ResNet-50, Brain Sci, 9, 212, 10.3390/brainsci9090212 · DOI · Paper page
- Jin, 2016, Heterogeneous multimodal biomarkers analysis for Alzheimer’s disease via Bayesian network, EURASIP J Bioinform Syst Biol, 2016, 12, 10.1186/s13637-016-0046-9 · DOI
- Martinez-Murcia, 2020, Studying the manifold structure of Alzheimer's Disease: a deep learning approach using convolutional autoencoders, IEEE J Biomed Health Inform, 24, 17, 10.1109/JBHI.2019.2914970 · DOI · Paper page
- Zhu, 2016, COMPASS: a computational model to predict changes in MMSE scores 24-months after initial assessment of Alzheimer’s disease, Sci Rep, 6, 34567, 10.1038/srep34567 · DOI
- Bucholc, 2019, A practical computerized decision support system for predicting the severity of Alzheimer's disease of an individual, Expert Syst Appl, 130, 157, 10.1016/j.eswa.2019.04.022 · DOI
- Kim, 2017, Longitudinal study-based dementia prediction for public health, Int J Environ Res Public Health, 14, 983, 10.3390/ijerph14090983 · DOI
- Lee, 2019, MildInt: deep learning-based multimodal longitudinal data integration framework, Front Genet, 10, 617, 10.3389/fgene.2019.00617 · DOI · Paper page
- Geifman, 2018, Data-driven identification of endophenotypes of Alzheimer’s disease progression: implications for clinical trials and therapeutic interventions, Alz Res Therapy, 10, 1, 10.1186/s13195-017-0332-0 · DOI
- Khanna, 2018, Using multi-scale genetic, neuroimaging and clinical data for predicting Alzheimer’s disease and reconstruction of relevant biological mechanisms, Sci Rep, 8, 1, 10.1038/s41598-018-29433-3 · DOI · Paper page
- Tunvirachaisakul, 2018, Characteristics of mild cognitive impairment using the Thai version of the consortium to establish a registry for Alzheimer’s disease tests: a multivariate and machine learning study, Dement Geriatr Cogn Disord, 45, 38, 10.1159/000487232 · DOI
- Bin-Hezam, 2019, A machine learning approach towards detecting dementia based on its modifiable risk factors, Int J Adv Comput Sci Appl, 10, 148
- McCoy, 2020, Stratifying risk for dementia onset using large-scale electronic health record data: a retrospective cohort study, Alzheimers Dement, 16, 531, 10.1016/j.jalz.2019.09.084 · DOI
- Moreira, 2018, A hybrid data mining model for diagnosis of patients with clinical suspicion of dementia, Comput Methods Programs Biomed, 165, 139, 10.1016/j.cmpb.2018.08.016 · DOI
- Uspenskaya-Cadoz, 2019, Machine learning algorithm helps identify non-diagnosed prodromal Alzheimer’s disease patients in the general population, J Prev Alzheimers Dis, 6, 185
- Kang, 2019, Prediction of cognitive impairment via deep learning trained with multi-center neuropsychological test data, BMC Med Inform Decis Mak, 19, 231, 10.1186/s12911-019-0974-x · DOI
- Lins, 2017, Using artificial neural networks to select the parameters for the prognostic of mild cognitive impairment and dementia in elderly individuals, Comput Methods Programs Biomed, 152, 93, 10.1016/j.cmpb.2017.09.013 · DOI
- Lahmiri, 2019, Performance of machine learning methods applied to structural MRI and ADAS cognitive scores in diagnosing Alzheimer’s disease, Biomed Signal Process Control, 52, 414, 10.1016/j.bspc.2018.08.009 · DOI
- An, 2020, Deep ensemble learning for Alzheimer's disease classification, J Biomed Inform, 105, 103411, 10.1016/j.jbi.2020.103411 · DOI · Paper page
- Candemir, 2020, Predicting rate of cognitive decline at baseline using a deep neural network with multidata analysis, J Med Imaging (Bellingham), 7, 044501
- Nie, 2017, Modeling disease progression via multisource multitask learners: A case study with Alzheimer’s disease, IEEE Trans Neural Netw Learn Syst, 28, 1508, 10.1109/TNNLS.2016.2520964 · DOI
- Pölsterl, 2019, Joint European Conference on Machine Learning and Knowledge Discovery in Databases
- Jarrett, 2020, Dynamic prediction in clinical survival analysis using temporal convolutional networks, IEEE J Biomed Health Inform, 24, 424, 10.1109/JBHI.2019.2929264 · DOI
- Pillai, 2019, Modeling multi-view dependence in Bayesian networks for Alzheimer's disease detection, Stud Health Technol Inform, 264, 358
- Mondelli, 2019, International Conference on Conceptual Modeling
- Johnson, 2016, MIMIC-III, a freely accessible critical care database, Sci Data, 3, 1, 10.1038/sdata.2016.35 · DOI · Paper page
- Yiannopoulou, 2019, Reasons for failed trials of disease-modifying treatments for Alzheimer Disease and their contribution in recent research, Biomedicines, 7, 97, 10.3390/biomedicines7040097 · DOI · Paper page
- Sperling, 2014, The A4 study: stopping AD before symptoms begin?, Sci Transl Med, 6, 228fs13, 10.1126/scitranslmed.3007941 · DOI · Paper page
- Giannoula, 2018, Identifying temporal patterns in patient disease trajectories using dynamic time warping: a population-based study, Sci Rep, 8, 1, 10.1038/s41598-018-22578-1 · DOI
- Zhou, 2019, Automatic extraction and assessment of lifestyle exposures for Alzheimer’s disease using natural language processing, Int J Med Inform, 130, 103943, 10.1016/j.ijmedinf.2019.08.003 · DOI
- Wu, 2020, Deep learning in clinical natural language processing: a methodical review, J Am Med Inform Assoc, 27, 457, 10.1093/jamia/ocz200 · DOI · Paper page
- Lustgarten, 2020, Veterinary informatics: forging the future between veterinary medicine, human medicine, and One Health initiatives—a joint paper by the Association of Veterinary Informatics (AVI) and the CTSA One Health Alliance (COHA), JAMIA Open, 3, 306, 10.1093/jamiaopen/ooaa005 · DOI
Cited by
Machine learning models identify predictive features of patient mortality across dementia types
Zhang, J., Song, L., Miller, Z., Chan, K. C. G., & Huang, K.-L. (2024) · Communications Medicine · doi:10.1038/s43856-024-00437-7 · Cited by 20
Richter-Laskowska, M., Sobotnicka, E., & Bednorz, A. (2025) · Scientific Reports · doi:10.1038/s41598-025-90460-y · Cited by 16
“Most of the research focuses on predicting the progression of AD using publicly available standardized multimodal datasets that combine neuroimaging with non-imaging clinical data 10,15 .”
InfluentialAlam, M. S. B., Lameesa, A., Sharmin, S., Afrin, S., Ahmed, S. F., Nikoo, M. R., & Gandomi, A. H. (2025) · Digital Communications and Networks · doi:10.1016/j.dcan.2025.04.001 · Cited by 9
Xu, J., Yin, R., Huang, Y., Gao, H., Wu, Y., Guo, J., Smith, G. E., DeKosky, S. T., Wang, F., Guo, Y., et al. (2023) · doi:10.1101/2023.07.27.23293270 · Cited by 5
“…have made it possible to identify the patterns and subtypes of AD progression using data-driven approaches reflecting real-world clinical practice, 16 as they contain a wide variety of critical health events of patients collected through routine care, including diagnostic codes, medication use,…”
Method
Metadata
- Authors
- Kumar, S., Oh, I., Schindler, S., Lai, A. M., Payne, P. R. O., & Gupta, A.
- Venue
- JAMIA Open
- Publisher
- Oxford University Press (OUP)
- Published
- 2021-07-01
- Volume
- 4
- Issue
- 3
- Pages
- ooab052-ooab052
- ISSN
- 2574-2531 (ISSN-L)
- OpenAlex
- W3188044527
- Cited by
- 120
- References
- 15
- FWCI
- 4.40
- Type
- journal article
- Language
- en
- Open access
- gold
- Funders
- Centene Corporation (P19-00559)
- Washington University-Centene ARCH Personalized Medicine Initiative (K23AG053426)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.